CNS循证指南:立体定向放射外科治疗功能性垂体腺瘤
美国神经外科医师大会(CNS)系统综述了立体定向放射外科(SRS)治疗成人功能性垂体腺瘤(FPA)的文献,检索至2021年6月8日,最终纳入21篇符合标准的研究。基于III类证据提出2条III级推荐:SRS、大分割SRS、分次(>5次)放疗及常规放疗均可提供良好的影像学控制,但激素下降和内分泌缓解率不一,且激素下降可持续至治疗后10年;SRS前继续内分泌抑制治疗可能不影响影像学控制。
要点
- SRS及分次放疗对FPA有良好影像学控制,内分泌缓解率不一。
- 激素下降可持续至SRS或分次放疗后10年。
- SRS前可继续内分泌抑制治疗,可能不影响影像学控制。
核心结论
- 基于III类证据,SRS、大分割SRS、分次(>5次)放疗和常规放疗可提供良好的影像学控制,但激素下降和内分泌缓解率存在差异。
研究设计与样本
- 系统综述检索PubMed和Embase从建库至2021年6月8日的文献,共1842篇摘要,343篇全文符合 eligibility,最终21篇纳入证据表。
主要发现
- 21篇符合入选标准的研究纳入证据表,提供III类证据支持2条III级推荐。
- SRS和分次放疗后激素下降可持续至治疗后10年。
关键数值与推荐
- SRS、大分割SRS、分次(>5次)放疗和常规放疗可提供良好影像学控制,激素下降和内分泌缓解率不一。
- SRS前继续内分泌抑制治疗可能不影响影像学控制。
临床怎么用
- 临床医生可依据III级推荐,在成人FPA多学科决策中考虑SRS或分次放疗,并可在SRS前继续内分泌抑制治疗。
局限性
- 证据等级为III类,推荐级别为III级,证据强度有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with functioning pituitary adenomas (FPA) require a multidisciplinary team-based approach to select best medical, surgical, and radiation treatments, including stereotactic radiosurgery (SRS). OBJECTIVE: The aim of this study was to provide evidence-based recommendations on the use of SRS for adult patients with FPA. METHODS: PubMed and Embase were searched from data base inception to June 8, 2021. Full-text articles were then screened using published exclusion/inclusion criteria. Evidence tables were developing based on data extraction from the full-text reviews, and evidence-based recommendations were finalized. RESULTS: Of the total 1842 abstracts pertinent to this topic, 343 full articles met eligibility. Of these, 21 met entry criteria and were included in the evidence tables. The provided Class III evidence supported 2 Level III recommendations: 1. SRS, hypofractionated SRS, fractionated (>5 fractions) radiotherapy, and conventional radiation therapy provide excellent radiographic control with variable hormonal reduction and endocrine remission rates. For SRS and fractionated radiotherapy hormonal reduction may continue for up to 10 years after treatment. 2. Clinicians may continue to administer endocrine suppressive medical treatment before SRS as this may not affect radiographic control. CONCLUSION: This systematic review provides evidence-based recommendations to guide providers caring for adult patients with FPA when making decisions pertinent to radiosurgery. The CNS Guidelines Committee will continue to pursue timely updates to further improve the care of patients with this diagnosis.
引用
- Green S, Lehrer EJ, Cifarelli CP, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Radiosurgery for Patients With Functioning Pituitary Adenomas. Neurosurgery. 2025. PMID: 40815129. doi:10.1227/neu.0000000000003582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。